IP Library Granted Patent US 10,828,152
Granted Patent B2
US 10,828,152 · App. 15/673,990 · Granted Nov 10, 2020

Heart chamber prosthetic valve implant with base, spring and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function

Inventor: Jeffrey W. Chambers (Maple Grove, MN)
Assignee: 4C Medical Technologies, Inc.
A61F2/2418A61F2/24A61F2/2409A61F2/2412A61F2/2442A61F2/2445A61F2/2454A61F2/2469A61F2/2487A61F2/2463A61F2210/0014A61F2230/0069A61F2250/0048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,828,152
App. No.
15/673,990
Granted
Nov 10, 2020
Kind
B2
Abstract

Various embodiments of the present invention comprise a single-chamber collapsible and expandable prosthetic valve implant device comprising the following capabilities: (1) preservation of native valve functionality; (2) initial preservation of native valve functionality with subsequent full replacement of native valve functionality; (3) full replacement of native valve functionality; and/or (4) mitigation of the prolapsing distance of the dysfunctional leaflets by preventing the anterior excursion of the prolapsing leaflets above the upper annular surface and into the left atrial chamber in order to preserve native leaflet functionality for as long as possible. The expanded and implanted device does not extend beyond the boundaries of the subject heart chamber, e.g., the left atrium, thereby enabling the preservation of any remaining native valve functionality with subsequent full replacement of native valve functionality if and when needed.

Claims (32)

1. A device configured for expanded implantation within a heart chamber that is in fluid communication with an annulus comprising an upper annular surface and native leaflets located within the annulus, the device comprising:

a base section comprising a lower surface;

an atrial dome;

an intermediate section operatively attached to the base section and the atrial dome,

wherein the intermediate section comprises a plurality of springs or shock absorbers, the plurality of springs or shock absorbers adapted to enable flexing of the intermediate section in a plurality of radial directions when the device is in expanded implantation within the heart chamber, wherein each one of the plurality of springs or shock absorbers define a first end opposite a second end, wherein the first end is operatively connected with the atrial dome and wherein the second end is operatively connected with the base section, and further wherein each immediately adjacent ones of the plurality of springs or shocks are spaced apart and free of direct interconnection between each other; and

a central cylinder valve support comprising a lower surface, the central cylinder valve support operatively attached to the base section and comprising at least one prosthetic valve leaflet operatively attached therein.

2. The device of claim 1 , further comprising the at least one prosthetic valve leaflet attached within the central cylinder valve support at the lower surface of the central cylinder valve support.

3. The device of claim 1 , further comprising the at least one prosthetic valve leaflet attached within the central cylinder valve support at a point that is located above the lower surface of the central cylinder valve support.

4. The device of claim 1 , wherein the heart chamber comprises the left atrium and the native valve comprises the mitral valve comprising native leaflets.

5. The device of claim 1 , further comprising the expanded and implanted device comprising no structural engagement presence in, or engagement with, the native valve leaflets.

6. The device of claim 4 , further comprising the expanded and implanted device comprising no structural presence in, or engagement with, one or more of the group consisting of: the native mitral valve comprising native leaflets, the left ventricle, and a pulmonary artery.

7. The device of claim 1 , wherein the atrial dome comprises a wire boundary.

8. The device of claim 7 , wherein the atrial dome comprises an open structure defined by the wire boundary.

9. The device of claim 1 , wherein the atrial dome comprises a covered structure defined by a wire boundary.

10. The device of claim 1 , the intermediate section comprising one or more wires operationally connected between the base section and the atrial dome.

11. A method for preserving the functionality of a patient's at least partially malfunctioning native heart valve with an implanted prosthetic heart valve device within a heart chamber, comprising:

providing a device according to claim 1 , expanding and implanting the device within a single heart chamber wherein the heart chamber is at least partially protected from retrograde flow by the at least partially malfunctioning native valve; and

preserving the remaining normal native functionality of the at least partially malfunctioning native valve with the expanded and implanted device.

12. The method of claim 11 , wherein the single chamber of the heart comprises the left atrium and the native valve is the mitral valve comprising native leaflets.

13. The method of claim 12 , comprising ensuring the expanded and implanted device has no structural presence in, or engagement with, at least one of the group consisting of: the mitral valve comprising native leaflets, the patient's left ventricle, and a pulmonary artery.

14. A method for preserving and supplementing the functionality of a patient's at least partially malfunctioning native heart valve with an implanted prosthetic heart valve device within a heart chamber comprising an annulus comprising an upper annular surface defining an annular plane that is coextensive with the upper annular surface, comprising:

providing a device according to claim 1 , expanding and implanting the device within a single heart chamber wherein the heart chamber is at least partially protected from retrograde flow by the at least partially malfunctioning native valve; and

preserving and supplementing the remaining normal native functionality of the at least partially malfunctioning native valve with the implanted device.

15. The method of claim 14 , wherein the single chamber of the heart comprises the left atrium and the native valve is the mitral valve.

16. The method of claim 15 , further comprising ensuring the expanded and implanted device has no structural presence in, or engagement with, at least one of the group consisting of: the mitral valve comprising native leaflets, the patient's left ventricle, and a pulmonary artery.

17. A method for preserving and supplementing any remaining native functionality of a patient's at least partially malfunctioning native heart valve and replacing the heart valve functionality with an implanted prosthetic heart valve device with an implanted prosthetic heart valve device within a heart chamber comprising an annulus comprising an upper annular surface and defining an annular plane that is coextensive with the upper annular surface, comprising:

providing a device according to claim 1 ;

expanding and implanting the device within a single heart chamber wherein the heart chamber is at least partially protected from retrograde flow by the at least partially malfunctioning native valve;

preserving and supplementing the remaining normal native functionality of the malfunctioning native valve with the implanted device; and

completely replacing the native valve functionality when the native valve ceases to provide any normal native functionality.

18. The method of claim 17 , wherein the single chamber of the heart is the left atrium and the native valve is the mitral valve comprising native leaflets.

19. The method of claim 18 , further comprising ensuring the expanded and implanted device has no structural engagement with at least one of the group consisting of: the native mitral valve comprising leaflets, the patient's left ventricle, and a pulmonary artery.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2020
From: CHAMBERS, JEFFREY W.
To: 4C MEDICAL TECHNOLOGIES, INC.
Reel/Frame 051821/0239 →
Continuity (4)
Provisional Application 62373541 · Aug 11, 2016
Provisional Application 62373560 · Aug 11, 2016
Provisional Application 62373551 · Aug 11, 2016
Related Publication 20180042720A1 · Feb 15, 2018
Cited By (10)
US 12,232,991 US 12,453,630 US 12,544,226 US 12,582,520 US 12,588,988 US 12,588,989 US 12,588,998 US 12,594,164 US 12,599,481 US 12,636,146